Effect of fecal microbiota transplantation in patients with slow transit constipation and the relative mechanisms based on the protein digestion and absorption pathway

Table 2 Clinical outcomes in patients undergoing FMT

Project	B1	B2	B3	B4
Clinical improvement rate (%)	0	62.5% (5/8)	50% (4/8)	62.5% (5/8)
Clinical remission rate (%)	0	87.5% (7/8)	62.5% (5/8)	75% (6/8)
WCS	12.12 ± 4.05	7.62 ± 3.85^#	6.87 ± 4.15^#	7.12 ± 3.52^#
GIQLI	89.12 ± 16.54	115.37 ± 17.18^#	123.25 ± 12.04^#	131.12 ± 6.22^#
HAMD	7.75 ± 6.73	4.12 ± 2.69^#	2.87 ± 2.29^#	2.37 ± 2.06^#

Data are expressed as the M ± SD
B1, before the treatment; B2, after the first treatment; B3, after second treatment; B4, after third treatment
^#p < 0.05 and the difference was statistically significant compared with B1 (before the treatment) values

ISSN: 1479-5876